J&J to Sell LifeScan Unit for $2.1B

6/12/18

By Douglas W. House, SA

Johnson & Johnson (NYSE:JNJ) has accepted a binding offer from Platinum Equity to acquire its LifeScan business for $2.1B.

LIfeScan's core business is glucose monitoring, led by its OneTouch line of products.

The transaction should close by year-end.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.